title: Annual drug update: 2010 in review.
abstract: In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available.
authors.affiliation: Trauma Intensive Care Unit, University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, PA, USA.
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Belavic
mesh_terms: D017311:Amlodipine; D000959:Antihypertensive Agents; D001378:Azasteroids / Q000008:administration & dosage*; D002981:Clindamycin; D003879:Dermatologic Agents; D004338:Drug Combinations; D000068538:Dutasteride; D006801:Humans; D006852:Hydrochlorothiazide; D007093:Imidazoles; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage*; D000077409:Tamsulosin; D013777:Tetrazoles; D014212:Tretinoin; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000959:Antihypertensive Agents; D001378:Azasteroids; D003879:Dermatologic Agents; D004338:Drug Combinations; D007093:Imidazoles; D013449:Sulfonamides; D013777:Tetrazoles; C552718:Tribenzor; C557521:Veltin Gel; D006852:Hydrochlorothiazide; D017311:Amlodipine; D002981:Clindamycin; D014212:Tretinoin; D000077409:Tamsulosin; D000068538:Dutasteride